Physician profile
River A Gates
NPI 1417581265
$2,505.50
in general payments reported to CMS, 2019-2025
13 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $636 · 2022: $863 · 2023: $315 · 2024: $307 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $697.19 | 2022-2025 | Airsupra |
| Glaxosmithkline, LLC. | $292.81 | 2021-2023 | Arexvy, Shingrix |
| Abbvie INC. | $270.89 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.73 | 2021-2024 | Jardiance |
| Astellas Pharma US INC | $209.79 | 2024-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $165.34 | 2021-2022 | |
| Medtronic, INC. | $139.43 | 2025 | Synchromedii |
| Axsome Therapeutics, INC. | $124.99 | 2023 | Auvelity |
| Lilly USA, LLC | $124.74 | 2024 | Zepbound |
| Janssen Pharmaceuticals, INC | $116.64 | 2021 | |
| Novo Nordisk INC | $91.80 | 2022 | |
| Pfizer INC. | $36.65 | 2022 | |
| Philips North America LLC | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw River Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.